KRAS and cancer: Growing evidence exists of the role of small non-coding RNA, particularly micro-RNA (miRNA’s), in controlling the key biological process, including deciding the fate of cancer treatment [19], such as the tumor-suppressive effect of miR-193a-3p in lung cancer through targeting KRAS expression [20,21].